Our expansion plans for future success


In 2019, our new production plant was opened in Schwerin in north-eastern Germany. Since then, we have been steadily expanding the plant capacities for our infusion and injection business. The Schwerin site supports our global growth ambitions and provides the production space and technical infrastructure for our medium to long-term growth. With this plant, we are planning for the future in order to always be able to reliably respond to the demand of our customers and partners.

Our future production site


For over 15 years we have been supplying products such as our reusable ServoPen and YpsoPen and, more recently, our disposable UnoPen to China. We have also had an office in China for seven years. Our employees support our business with local pharmaceutical customers. We are currently evaluating possible production sites in order to be able to produce locally in the future and supply the Chinese market directly.

Rafael Navajo, Beat Kaser, Hanspeter Mock, Albert Castellanos und Simon Michel (left to right).

Our new digital hub in Barcelona


On 3 May 2022, our new Software Delivery Centre in Barcelona was officially opened: Albert Castellanos, Minister of Economy and Competitiveness and our CEO, Simon Michel, laid the foundation for a flourishing collaboration in Spain in the presence of numerous media representatives.

Digitalization in Barcelona

Digitalization of product portfolio


One of today’s mega trends in healthcare and MedTech is digitalization. Ypsomed is shaping this trend with creative concepts and new products under the umbrella brands Diabetes Care and Delivery Systems. The establishment of a new software development site in Barcelona is in full swing. This expansion strengthens our development of digital services in the area of app and cloud technologies, which are already proving important today and which will become even more important for us and our customers in the future.